Skip to main content
. 2020 Jun 16;94(13):e00592-20. doi: 10.1128/JVI.00592-20

FIG 9.

FIG 9

The effect of the cholesterol-modifying drug filipin on E30B infection. (A) Quantitative RT-PCR measuring the intracellular accumulation of E30B RNA in RD cells treated with different concentrations of the caveolae pathway inhibitor filipin, 6 h p.i. Results are presented as mean values of 3 replicates (± SD). CTRL E30B, control infection without filipin. Statistical significance was determined using an unpaired t-test. ****, P < 0.0001. (B) Cell viability assay of RD cells after treatment with different filipin concentrations for 6 h. Results are presented as mean values of 3 replicates (± SD). CTRL, untreated control cells.